What is MedArrive?
MedArrive operates a sophisticated, fully integrated care management platform designed to bridge the persistent gap between virtual consultations and physical medical intervention. By effectively marrying physician-led telemedicine with hands-on care delivered by EMS professionals, the company provides a seamless continuity of care that extends directly into the patient's home. This hybrid approach addresses the critical need for accessible, high-quality medical expertise while reducing the operational burden on traditional healthcare providers and payers. As a result, MedArrive is uniquely positioned to improve health outcomes for complex patient populations, effectively transforming the home into a viable, safe, and efficient clinical setting.
How much funding has MedArrive raised?
MedArrive has raised a total of $37.5M across 3 funding rounds:
Angel/Seed
$4.5M
Series A
$25M
Other Financing Round
$8M
Angel/Seed (2020): $4.5M with participation from Kleiner Perkins and Define Ventures Management
Series A (2021): $25M led by 7wireVentures, Define Ventures Management, Kleiner Perkins, Redesign Health, Section 32, Bayer, and SCAN Health Plan
Other Financing Round (2023): $8M supported by Cobalt Ventures
Key Investors in MedArrive
7wireVentures
7wire Ventures is a firm that builds and invests in early-stage digital health companies focused on creating informed and connected health consumers.
Define Ventures Management
Define Ventures is an early-stage venture capital firm that focuses on investing in digital health companies.
Kleiner Perkins
Kleiner Perkins is a Menlo Park-based venture capital firm that invests in early and growth-stage technology and life-science companies.
What's next for MedArrive?
With the recent strategic investment, MedArrive is poised to accelerate its national expansion and deepen its integration with major health plans and provider networks. The company's focus will likely shift toward scaling its operational footprint and enhancing its proprietary technology stack to support more complex care pathways. By leveraging the expertise of its strategic backers, MedArrive is well-positioned to navigate the evolving regulatory environment and capitalize on the growing demand for home-based, value-based care models. Future growth will be defined by the company's ability to maintain clinical quality at scale while demonstrating measurable cost savings for its enterprise partners.
See full MedArrive company page
